Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 205.19 USD -0.52% Market Closed
Market Cap: 363B USD

Intrinsic Value

The intrinsic value of one ABBV stock under the Base Case scenario is 158 USD. Compared to the current market price of 205.19 USD, Abbvie Inc is Overvalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABBV Intrinsic Value
158 USD
Overvaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Abbvie Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ABBV
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ABBV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Abbvie Inc
NYSE:ABBV
US
Biotechnology
Market Cap
362.2B USD
IPO
Jan 2, 2013
US
Biotechnology
Market Cap
362.2B USD
IPO
Jan 2, 2013
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

With Humira’s patent protection expiring in key markets, AbbVie faces an impending revenue cliff that may be difficult to replace with newer therapies in the short term, potentially straining cash flows and earnings.

Bull Theses

Skyrizi and Rinvoq have shown strong clinical data and commercial traction, signifying AbbVie’s potential to sustain leadership in immunology and mitigate the Humira patent cliff through these next-generation therapies.

Show More Less
How do you feel about ABBV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Abbvie Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Abbvie Inc

Current Assets 25.6B
Cash & Short-Term Investments 5.6B
Receivables 10.9B
Other Current Assets 9.1B
Non-Current Assets 109.6B
Long-Term Investments 279m
PP&E 5.1B
Intangibles 95B
Other Non-Current Assets 9.1B
Efficiency

Free Cash Flow Analysis
Abbvie Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Abbvie Inc

Revenue
56.3B USD
Cost of Revenue
-16.9B USD
Gross Profit
39.4B USD
Operating Expenses
-22.9B USD
Operating Income
16.5B USD
Other Expenses
-12.3B USD
Net Income
4.2B USD
Fundamental Scores

ABBV Profitability Score
Profitability Due Diligence

Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROE
72/100
Profitability
Score

Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

ABBV Solvency Score
Solvency Due Diligence

Abbvie Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
Positive Net Debt
27/100
Solvency
Score

Abbvie Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 219.74 USD with a low forecast of 174.73 USD and a high forecast of 263.55 USD.

Lowest
Price Target
174.73 USD
15% Downside
Average
Price Target
219.74 USD
7% Upside
Highest
Price Target
263.55 USD
28% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Apr 3, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for ABBV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ABBV Insider Trading
Buy and sell transactions by insiders

ABBV News

Other Videos
What is the Intrinsic Value of one ABBV stock?

The intrinsic value of one ABBV stock under the Base Case scenario is 158 USD.

Is ABBV stock undervalued or overvalued?

Compared to the current market price of 205.19 USD, Abbvie Inc is Overvalued by 23%.

Back to Top